342 related articles for article (PubMed ID: 26035030)
1. Spontaneous, Life-Threatening Hemorrhagic Cardiac Tamponade Secondary to Rivaroxaban.
Kham NM; Song M
Am J Ther; 2016; 23(4):e1128-31. PubMed ID: 26035030
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban-induced hemorrhagic pericardial tamponade in end-stage renal disease.
Rapista N; Sarkar S; Chaudhary R
J Thromb Thrombolysis; 2020 Nov; 50(4):982-983. PubMed ID: 32495012
[No Abstract] [Full Text] [Related]
3. Cardiac Tamponade Associated with Rivaroxaban.
Boone S
Del Med J; 2015 Jul; 87(7):206-7. PubMed ID: 26285318
[TBL] [Abstract][Full Text] [Related]
4. Isolated hemopericardium associated with rivaroxaban: first case report.
Shivamurthy P; Brar N; Therrien ML
Pharmacotherapy; 2014 Sep; 34(9):e169-72. PubMed ID: 25074401
[TBL] [Abstract][Full Text] [Related]
5. Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage.
Jun JH; Hwang JC
JAMA Ophthalmol; 2015 Oct; 133(10):1184-6. PubMed ID: 26111247
[TBL] [Abstract][Full Text] [Related]
6. The role of rivaroxaban in atrial fibrillation and acute coronary syndromes.
Reddy P; Giugliano RP
J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):526-32. PubMed ID: 24659084
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous splenic rupture due to rivaroxaban.
Nagaraja V; Cranney G; Kushwaha V
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29507024
[TBL] [Abstract][Full Text] [Related]
8. [Good efficacy and safety profile in clinical practice].
MMW Fortschr Med; 2015 Nov; 157(20):66-7. PubMed ID: 26977521
[No Abstract] [Full Text] [Related]
9. Intravenous thrombolysis for acute ischemic stroke in a patient receiving rivaroxaban.
Landais A; Ginoux C
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):e73-4. PubMed ID: 25561312
[TBL] [Abstract][Full Text] [Related]
10. Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.
Gianni C; DI Biase L; Mohanty S; Trivedi C; Bai R; Al-Ahmad A; Burkhardt JD; Gallinghouse GJ; Horton RP; Sanchez JE; Hranitzky PM; Lakkireddy D; Mansour MC; Santangeli P; Zado ES; Marchlinski FE; Beheiry S; Hao SC; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2016 Apr; 27(4):399-403. PubMed ID: 26756289
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal haematoma in a postoperative ALIF patient taking rivaroxaban for atrial fibrillation.
Deekonda P; Stokes OM; Chan D
Eur Spine J; 2019 Apr; 28(4):688-692. PubMed ID: 27807780
[TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses.
Spencer RJ; Amerena JV
Am J Cardiovasc Drugs; 2015 Dec; 15(6):395-401. PubMed ID: 26062914
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban-associated intracranial hemorrhage in Saudi atrial fibrillation patients.
Alkhotani A; Alrishi N; Alharthi M; Alzahrani W
Medicine (Baltimore); 2020 Nov; 99(48):e23316. PubMed ID: 33235091
[TBL] [Abstract][Full Text] [Related]
14. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy.
Sholzberg M; Xu Y
JAMA; 2018 Oct; 320(14):1485-1486. PubMed ID: 30242329
[No Abstract] [Full Text] [Related]
15. Initiation of rivaroxaban in patients with nonvalvular atrial fibrillation at the primary care level: the Swiss Therapy in Atrial Fibrillation for the Regulation of Coagulation (STAR) Study.
Engelberger RP; Noll G; Schmidt D; Alatri A; Frei B; Kaiser WE; Kucher N
Eur J Intern Med; 2015 Sep; 26(7):508-14. PubMed ID: 25935131
[TBL] [Abstract][Full Text] [Related]
16. Delayed cardiac tamponade: A rare but life-threatening complication of catheter ablation.
Yetter E; Brazg J; Del Valle D; Mulvey L; Dickman E
Am J Emerg Med; 2017 May; 35(5):803.e1-803.e3. PubMed ID: 27989537
[TBL] [Abstract][Full Text] [Related]
17. Hemorrhagic Cardiac Tamponade Associated with Apixaban: A Case Report and Systematic Review of Literature.
Asad ZUA; Ijaz SH; Chaudhary AMD; Khan SU; Pakala A
Cardiovasc Revasc Med; 2019 Nov; 20(11S):15-20. PubMed ID: 31088720
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.
Barón-Esquivias G; Fernández-Avilés F; Atienza F; Pastor Pueyo P; Toro R; Sanmartín Fernández M
Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):341-53. PubMed ID: 25797900
[TBL] [Abstract][Full Text] [Related]
19. Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation.
Kauffmann S; Chabanne R; Coste A; Longeras F; Sinegre T; Schmidt J; Samama CM; Constantin JM; Lebreton A
A A Case Rep; 2015 Jun; 4(11):151-4. PubMed ID: 26035221
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
Nairooz R; Sardar P; Pino M; Aronow WS; Sewani A; Mukherjee D; Paydak H; Maskoun W
Int J Cardiol; 2015; 187():345-53. PubMed ID: 25839640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
